生命科学资讯

Takeda inks $1.7B AI drug discovery deal with Iambic Therapeutics

Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena

Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'

CSL signs on to $328M research collab with option for Memo’s immunoglobulin antibody tech

How AI Is reshaping clinical trials and market access

The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align

UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge

Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals

Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study

Chutes & Ladders—Moderna CMO steps down in leadership mix-up

Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk

Medtronic hit with $382M antitrust ruling over surgical device monopoly

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

NICE greenlights Abbott's cardiac sensor implant for NHS

Astellas tops expectations as Vyloy sales surge outshines trial setback

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA

Flagship-founded antibody biotech Generate is latest to mull IPO

A cut above: Veradermics locks in $256M IPO and shares spike

Angitia raises $130M to challenge Amgen with bone-building bispecifics

GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop